aldosterone synthase inhibitors (Boehringer Ingelheim)

N/A

Report date: 2025/01/26 18:09:53
NME

Base Information

Drug Namealdosterone synthase inhibitors (Boehringer Ingelheim)
Drug Alias Namedihydrobenzisoxazole analogs (Boehringer)Non-Steroidal CYP11B2 Inhibitors (Boehringer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 11B2 inhibitors
TargetsCytochrome P450 11B2
Therapy Area/IndicationsKidney Failure, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoehringer Ingelheim Corp
China Registration ClassN/A

Develop Information

Active CompaniesBoehringer Ingelheim Corp
Inactive CompaniesN/A
Active IndicationsKidney Failure, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A